Coherus Oncology, Inc. (CHRS)
NASDAQ
$1.42+1.43%
As of Jul 20, 2026
Price history
Key statistics
- Market cap
- —
- P/E ratio
- —
- EPS
- —
- Volume
- 364,207
- 52-week high
- —
- 52-week low
- —
- Open
- $1.43
- Day high
- $1.43
- Day low
- $1.38
Financial highlights
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| 2025 | — | $168.02M | $1.43 |
| 2024 | — | $28.51M | $0.25 |
| 2023 | — | -$237.89M | -$2.53 |
| 2022 | — | -$291.75M | -$3.76 |
| 2021 | — | -$287.1M | -$3.81 |
About Coherus Oncology, Inc.
A company overview for Coherus Oncology, Inc. is coming soon.
Similar stocks
Related stocks will appear here soon.
Frequently asked questions
- What is Coherus Oncology, Inc.'s stock price today?
- CHRS is trading at $1.42 as of Jul 20, 2026.
- Does Coherus Oncology, Inc. pay a dividend?
- Coherus Oncology, Inc. did not pay a dividend in its most recent reported fiscal year.